Head-to-head · WeighScore
Clume Health vs Direct Meds
The verdict
Direct Meds takes it — 77.6/100 to 63.7/100.
Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Clume Health | Direct Meds |
|---|---|---|
| WeighScore | 63.7/100 | 77.6/100 |
| Grade | C | C+ |
| Scorecard rank | #265 | #35 |
| Semaglutide | $259/mo (Signature full dose, oral or injectable; $186/mo requires a 52-week plan) | $249/mo sublingual · $297/mo injectable |
| Tirzepatide | $259/mo (Signature full dose, oral or injectable; $186/mo requires a 52-week plan) | $299/mo sublingual · $399/mo injectable |
| Coverage | All 50 states plus Washington, D.C. | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #265 · C
Strengths
- One Signature price covers semaglutide or tirzepatide, injectable or oral, so switching molecule or route does not change the bill
- A separate microdose and maintenance program is priced on its own at $219 a month rather than sold as a discount on the main line
- Names four dispensing pharmacies with street addresses and phone numbers, which is more than most of the field publishes
- States service in all 50 states plus Washington, D.C. without contradicting itself elsewhere
- A full refund is available if the subscription is canceled within the first 72 hours and before the medication ships
Where it loses points
- Neither homepage hero price matches anything sold: $199 a month is advertised against real floors of $259 and $219, and $159 against a figure of $216 that itself needs a 12-week plan
- Both hero prices carry an asterisk that resolves to no footnote anywhere on the page
- The cheaper monthly figures are commitments — $186 needs 52 weeks and $200 needs 12 — printed on the same card as the month-to-month rate
- The refund policy promises a 24/7 patient support line and no phone number appears anywhere on the site; support is email only
- Whether the medication is compounded, and under 503A or 503B, is never stated
- No clinician is named. The Terms name only “the OpenLoop Medical Practices”, with no individual, no NPI and no medical group entity
Graded #35 · C+
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Strengths
- Rare oral/sublingual option in addition to injectable
- All-inclusive pricing with no separate membership fee
- Both molecules — semaglutide and tirzepatide
- Intro promotional pricing near $147
Where it loses points
- Compounded only — not FDA-approved
- Pricing is company-stated, not independently live-verified
- Newer and somewhat ambiguous (operates across multiple domains)
- States served are not disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.